Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-09-19 Szalay Aladar 10% owner Sale −23,920 $26.21 $627K 8,247
2023-09-19 Szalay Aladar 10% owner Sale −8,247 $27.16 $224K 0
2023-09-18 Szalay Aladar 10% owner Sale −27,365 $23.20 $635K 7,927
2023-09-18 Szalay Aladar 10% owner Sale −2,927 $24.17 $71K 5,000
2023-09-18 Thomas John Director Sale −3,334 $24.99 $83K 475,793
2023-09-15 Yu Yong VP, Clinical Trial Operations Exercise or conversion +10,400 $6.00 $62K 116,535
2023-09-15 Yu Yong VP, Clinical Trial Operations Sale −5,725 $21.56 $123K 110,810
2023-09-15 Yu Yong VP, Clinical Trial Operations Sale −4,675 $22.29 $104K 106,135
2023-09-15 Yu Yong VP, Clinical Trial Operations Exercise or conversion · Stock Option (right to buy) −10,400 229,253
2023-09-15 Thomas John Director Sale −2,245 $21.67 $49K 480,215
2023-09-15 Thomas John Director Sale −1,088 $22.38 $24K 479,127
2023-09-14 Szalay Aladar 10% owner Sale −11,405 $21.77 $248K 49,163
2023-09-14 Szalay Aladar 10% owner Sale −13,871 $22.31 $310K 35,292
2023-09-13 Yu Yong VP, Clinical Trial Operations Sale −29,800 $21.14 $630K 106,135
2023-09-13 Szalay Aladar 10% owner Sale −15,717 $21.26 $334K 63,883
2023-09-13 Szalay Aladar 10% owner Sale −3,315 $22.31 $74K 60,568
2023-09-13 Smither John W Director Sale −900 $20.78 $19K 6,920
2023-09-12 Szalay Aladar 10% owner Sale −6,538 $21.75 $142K 93,327
2023-09-12 Szalay Aladar 10% owner Sale −13,727 $22.51 $309K 79,600
2023-09-11 Zindrick Thomas President and CEO Grant or award · Stock Option (right to buy) +250,000 250,000

Page 13 of 16 · 315 trades